L.M. Kohn & Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
2,766
+94
| +4% | +$7.8K | 0.06% | 243 |
|
|
2025
Q1 | $217K | Buy |
2,672
+100
| +4% | +$8.11K | 0.06% | 253 |
|
|
2024
Q4 | $232K | Buy |
2,572
+25
| +1% | +$2.25K | 0.06% | 229 |
|
|
2024
Q3 | $252K | Hold |
2,547
| – | – | 0.06% | 230 |
|
|
2024
Q2 | $236K | Sell |
2,547
-131
| -5% | -$12.1K | 0.06% | 233 |
|
|
2024
Q1 | $254K | Hold |
2,678
| – | – | 0.07% | 218 |
|
|
2023
Q4 | $239K | Sell |
2,678
-71
| -3% | -$6.34K | 0.08% | 203 |
|
|
2023
Q3 | $201K | Sell |
2,749
-28
| -1% | -$2.05K | 0.07% | 212 |
|
|
2023
Q2 | $231K | Hold |
2,777
| – | – | 0.09% | 196 |
|
|
2023
Q1 | $212K | Sell |
2,777
-242
| -8% | -$18.4K | 0.09% | 195 |
|
|
2022
Q4 | $251K | Sell |
3,019
-310
| -9% | -$25.7K | 0.12% | 178 |
|
|
2022
Q3 | $265K | Sell |
3,329
-275
| -8% | -$21.9K | 0.13% | 162 |
|
|
2022
Q2 | $268K | Buy |
3,604
+234
| +7% | +$17.4K | 0.13% | 179 |
|
|
2022
Q1 | $303K | Buy |
+3,370
| New | +$303K | 0.12% | 185 |
|